Depression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression.
We are developing breakthrough technology for rapid, individualized, non-invasive treatment of major depression. A randomized controlled trial just published in the American Journal of Psychiatry showed relief of severe depression in 79% of people receiving active treatment. Read the Press Release
The FDA has awarded Breakthrough Device Designation to Magnus Medical’s non-invasive technology to rapidly treat major depressive disorder (MDD) in adults who have not responded to existing treatments.
Patrick J. Kennedy writes about a watershed moment brought about by neuroscientists to gain ground against diseases of the brain. Read the article.